EntrepreneurialCheck

Adventris Pharmaceuticals valuation

The estimated Adventris Pharmaceuticals valuation is $20.0M. This Adventris Pharmaceuticals valuation is an independent model output, not a verified appraisal, official mark, or financial advice. Founders: Jen Herbach net worth, Mark Yarchoan net worth, and William Collis net worth.

Jen Herbach
Founder
$6.67M
Mark Yarchoan
Founder
$6.67M
William Collis
Founder
$6.67M

Search this company in the directory

FAQ: Adventris Pharmaceuticals valuation and founders net worth

What is Adventris Pharmaceuticals's valuation?

The estimated Adventris Pharmaceuticals valuation is $20.0M. This Adventris Pharmaceuticals valuation is an independent model output, not a verified appraisal, official mark, or financial advice.

How much did Adventris Pharmaceuticals raise?

How much Adventris Pharmaceuticals raised, when disclosed, informs the estimated Adventris Pharmaceuticals valuation and Adventris Pharmaceuticals founders net worth on this hub. Independent estimate only — not financial advice.

Who founded Adventris Pharmaceuticals?

Jen Herbach, Mark Yarchoan, and William Collis founded Adventris Pharmaceuticals. Estimated net worth for each founder is on the linked profile. Figures are independent model estimates, not verified net worth.